Combining automated tools decreases CT radiation dose

Combining automatic tube voltage selection (ATVS) with automatic tube current modulation (ATCM) significantly decreases the radiation dose from abdominal and thoracic contrast-enhanced CT scans compared with ATCM alone, according to a study published in the August issue of the American Journal of Roentgenology.

CT radiation dose rates were reduced overall by 18 percent when combining the automatic tools, the study found. Rates were reduced 16.8 percent for CT chest scans and 18.4 percent for abdomen CT scans.

“Our study showed that by using ATVS an overall decrease in radiation dose of 18 percent is feasible,” wrote lead author Caroline Mayer, MD, of University Medical Center Mannheim in Mannheim, Germany, and colleagues. Other studies have come to similar conclusions, they added.

The retroactive study, which examined both radiation dose and image quality, examined 617 patients who all underwent contrast- enhanced chest or abdominal CT and divided them into two groups.

Group A included 317 patients who underwent CT with only ATCM and a fixed body mass index–adjusted tube voltage (120 kV or 100 kV). ATCM and ATVS were both used on the patients in group B.

The study also further analyzed those patients who benefited from ATVS and found that in a subgroup analysis, tube voltage was reduced in 35 percent of the abdomen examinations and 60 percent of the chest examinations.

“Given that tube voltage has an exponential relationship with radiation dose lowering the tube voltage may also be an effective approach to reduce radiation exposure because of the introduction of ATVS,” wrote the authors.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.